Skip to main content
. 2016 Mar 14;16:217. doi: 10.1186/s12885-016-2262-9

Table 1.

Patients characteristics and potential prognostic factors

ITT population N = 134
Gender (%) F/ M 15 (11.2)/119 (88.8)
Median Age (years, min/max) 65.3 [42.1–88.2]
[35–50 [N (%) 7 (5.2)
[50–65 [N (%) 57 (42.5)
[65–75 [N (%) 42 (31.3)
≥75 N (%) 28 (20.8)
Performance Status N (%)
0/1/ ≥ 2/Na 34 (25.4)/62 (46.3)/31 (23.1)/7 (5.2)
Metastases N (%)
Lung/Liver/Bone/Lung + Liver/Other 52 (38.8)/38 (28.4)/32 (23.9)/76 (56.7)/20 (14.9)
Creatinine Clearance N (%)
>60 ml/mn/[40–60] ml/mn/ < 40 ml/mn/Na 67 (50.0)/51 (38.1)/13 (9.7)/3 (2.2)
Haemoglobin N (%)
<= 10 (g/dl)/ > 10 (g/dl)/Na 32 (23.9)/100 (74.6)/2 (1.5)
Liver Function N (%)
Normal/Abnormal/Na 114 (85.1)/13 (9.7)/2 (1.5)
Chronic Constipation N (%)
No/Yes/Na 127 (94.8)/6 (4.5)/1 (0.7)
Prior Radiotherapy N (%) 28 (20.9)
Progression within 6 months after prior CT N (%) 112 (83.6)
Number of Advanced or Metastatic CT at Baseline [N, (%)] Total pts 128 (95.5)
1 CT lines 93 (69.4)
2 CT lines 31 (23.1)
3 CT lines 4 (3)
Patients with perioperative CT alone at Baseline [N, (%)] 5 (3.7 %)